Adults with metabolic syndrome, obesity, or inflammatory bowel syndrome who consume fermented dairy products such as yogurt and fermented milk have lower levels of the inflammatory marker TNFα in...
Mechanism
Synthesis from 1 study
Good bacteria in yogurt and fermented milk make chemicals that fix the gut lining and stop toxins from leaking into the blood. When fewer toxins enter the bloodstream, the body’s immune system stops producing excess TNFα, lowering inflammation.
Most probable mechanism
Good bacteria in fermented dairy survive digestion and produce short-chain fatty acids in the gut. These fatty acids strengthen the gut lining, preventing harmful bacterial toxins from leaking into the bloodstream. When fewer toxins enter the blood, immune cells in the body stop overreacting and produce less of the inflammatory chemical TNFα.
Probiotic bacteria from fermented dairy survive gastric transit and colonize the intestinal lumen, where they ferment dietary fibers to produce short-chain fatty acids including acetate, propionate, and butyrate.
Short-chain fatty acids bind to G-protein-coupled receptors on intestinal epithelial and immune cells, inhibiting NF-κB translocation and suppressing transcription of proinflammatory cytokines including TNFα.
Short-chain fatty acids and probiotic metabolites stimulate intestinal epithelial cells to produce anti-inflammatory cytokines IL-10 and TGF-β, which downregulate zonulin expression and promote assembly of tight junction proteins including occludin and claudins.
Enhanced tight junction integrity reduces paracellular permeability, preventing translocation of bacterial endotoxin LPS from the gut lumen into systemic circulation.
Reduced systemic LPS levels decrease activation of TLR4 on macrophages, resulting in diminished production and release of TNFα into the bloodstream.
Less supported by current evidence, but not ruled out
Good bacteria in fermented dairy outcompete harmful bacteria like H. pylori in the gut and stomach, and trigger the production of antimicrobial proteins that clear pathogens. Fewer pathogens mean less immune activation and lower TNFα levels.
Probiotic strains adhere to mucosal surfaces in the gastrointestinal tract, competing with pathogenic bacteria such as Helicobacter pylori for nutrient access and adhesion sites.
Probiotics secrete antimicrobial substances including bacteriocins and hydrogen peroxide that directly inhibit growth of pathogenic bacteria.
Interaction of probiotics with intestinal dendritic and epithelial cells activates TLR2 and NOD2 signaling, inducing production of antimicrobial peptides including LL-37 and defensins, and secretory IgA.
Elevated antimicrobial peptides and secretory IgA reduce pathogen colonization and dampen local inflammatory responses, decreasing systemic TNFα production.
Evidence from Studies
Supporting (1)
Community contributions welcome
Impact of Fermented Dairy on Gastrointestinal Health and Associated Biomarkers
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.